Dr Lu is a Postdoctoral Researcher with the Respiratory Translational Research Group at University of Tasmania. Her research pursuits involve gaining insights into the pathogenesis of chronic respiratory diseases, including COPD, IPF, lung cancer, and Asthma-COPD overlap (ACO), also actively examining the impact of vaping on human lung cellular changes.

Prof Phil Bardin is Professor of Respiratory Medicine in the Faculty of Medicine, Nursing & Health Sciences, Monash University, Melbourne, Australia. Currently he is also Director, Lung & Sleep Medicine, Monash University and Medical Centre, Melbourne.

Professor Price is the Founder and Head of the Observational and Pragmatic Research Institute (OPRI) in Singapore, conducting real-life, pragmatic, and observational research. Additionally, Professor Price is the Head of Optimum Patient Care (OPC) Global in Australia and the UK, a social enterprise focused on disease registries and quality improvement in healthcare. He established the Optimum Patient Care Research Database (OPCRD), which holds data from over 1100 general practices and 19.5 million patients in the UK. Professor Price leads the International Severe Asthma Registry (ISAR) and the Collaboration on Quality Improvement Initiative for Achieving Excellence in Standards of COPD Care (CONQUEST) registries.

Dr Sanjay Ramakrishnan is a respiratory physician from Perth, Western Australia. He completed his PhD on airways exacerbations at Oxford with Professor Mona Bafadhel in 2023. He is now an academic respiratory physician at Sir Charles Gairdner Hospital in Perth, WA.

Timothy Howarth is a young researcher currently finalising his PhD through Charles Darwin University. Timothy has a keen interest in Indigenous Australian health, with previous work in developmental origins of health and disease and childhood anaemia, though his current work focuses on chronic lung disease and sleep disorders

Wei WANG is a second year PhD student at RMIT. Her research project focuses on the interplay between lungs and adipose tissue, dissecting the mechanism underlying adipose tissue dysfunction in COPD. Using a conditioned media approach, she has established an in vitro model that recapitulates the lung-adipose tissue axis in COPD.

Arwel is a research fellow at the Respiratory Research@Alfred group of Monash University. He is currently the convenor of the COPD and Evidence-Based Medicine and Practice Special Interest Groups of TSANZ. Arwel’s main research interests are in the treatment and prevention of respiratory infections and exacerbations of chronic lung disease, which involves work in the areas of pulmonary rehabilitation, infection control, oral corticosteroids and vaccination.